14.97
price up icon1.56%   0.23
after-market Handel nachbörslich: 14.70 -0.27 -1.80%
loading
Schlusskurs vom Vortag:
$14.74
Offen:
$14.62
24-Stunden-Volumen:
27,142
Relative Volume:
0.55
Marktkapitalisierung:
$1.40B
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+0.00%
1M Leistung:
+11.14%
6M Leistung:
-1.12%
1J Leistung:
+0.00%
1-Tages-Spanne:
Value
$14.53
$14.97
1-Wochen-Bereich:
Value
$14.28
$15.09
52-Wochen-Spanne:
Value
$8.26
$27.10

Gyre Therapeutics Inc Stock (GYRE) Company Profile

Name
Firmenname
Gyre Therapeutics Inc
Name
Telefon
(619) 949-3681
Name
Adresse
12770 HIGH BLUFF DRIVE, SUITE 150, SAN DIEGO
Name
Mitarbeiter
391
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-04
Name
Neueste SEC-Einreichungen
Name
GYRE's Discussions on Twitter

Gyre Therapeutics Inc Stock (GYRE) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2021-04-29 Fortgesetzt Stephens Overweight
2021-02-10 Eingeleitet Piper Sandler Overweight
2020-05-21 Eingeleitet Raymond James Outperform
2019-01-04 Eingeleitet Oppenheimer Outperform
2018-02-12 Bestätigt B. Riley FBR, Inc. Buy
2018-02-09 Bestätigt Chardan Capital Markets Buy
2017-12-08 Eingeleitet B. Riley FBR, Inc. Buy
2017-06-12 Eingeleitet Chardan Capital Markets Buy
2017-06-06 Eingeleitet Ladenburg Thalmann Buy
2016-06-30 Eingeleitet Rodman & Renshaw Buy
Alle ansehen

Gyre Therapeutics Inc Aktie (GYRE) Neueste Nachrichten

pulisher
Oct 22, 2024

Gyre Therapeutics Announces Last Patient Completed Pivotal Phase 3 Trial Evaluating F351 for CHB-Associated Liver Fibrosis - The Manila Times

Oct 22, 2024
pulisher
Oct 22, 2024

Gyre Therapeutics (NASDAQ:GYRE) Stock Price Down 3.8%What's Next? - MarketBeat

Oct 22, 2024
pulisher
Oct 14, 2024

AQR Capital Management LLC Invests $778,000 in Mativ Holdings, Inc. (NYSE:MATV) - Defense World

Oct 14, 2024
pulisher
Oct 08, 2024

Gyre Therapeutics (NASDAQ:GYRE) Shares Gap UpStill a Buy? - MarketBeat

Oct 08, 2024
pulisher
Oct 03, 2024

Aligos Therapeutics (NASDAQ:ALGS) Shares Down 6.2% - Defense World

Oct 03, 2024
pulisher
Oct 03, 2024

Coronation Fund Managers Ltd. Buys 1,044 Shares of The Sherwin-Williams Company (NYSE:SHW) - Defense World

Oct 03, 2024
pulisher
Oct 03, 2024

Eaton Vance California Municipal Income Trust (NYSE:CEV) Major Shareholder Sells $282,451.70 in Stock - Defense World

Oct 03, 2024
pulisher
Oct 03, 2024

Gyre Therapeutics (NASDAQ:GYRE) Trading 3.3% HigherHere's What Happened - MarketBeat

Oct 03, 2024
pulisher
Oct 02, 2024

Gyre Therapeutics to Present at 8th Annual H.C. Wainwright MASH Investor Conference - The Manila Times

Oct 02, 2024
pulisher
Sep 18, 2024

Gyre Therapeutics, Inc. (NASDAQ:GYRE) Short Interest Down 7.0% in August - MarketBeat

Sep 18, 2024
pulisher
Sep 18, 2024

Applied Therapeutics, PowerFleet, VF Corp, Victoria's Secret And Other Big Stocks Moving Higher On Wednesday - Benzinga

Sep 18, 2024
pulisher
Sep 17, 2024

Gyre Therapeutics (NASDAQ:GYRE) Stock Price Up 4.9% - MarketBeat

Sep 17, 2024
pulisher
Sep 06, 2024

Gyre Therapeutics (NASDAQ:GYRE) Trading Up 6.6% - MarketBeat

Sep 06, 2024
pulisher
Sep 05, 2024

Gyre Therapeutics Inc (GYRE) Stock Price & Chart | Trade Now - Capital.com

Sep 05, 2024
pulisher
Sep 04, 2024

Gyre Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference - ForexTV.com

Sep 04, 2024
pulisher
Sep 03, 2024

Gyre Therapeutics (NASDAQ:GYRE) Shares Down 8.9% - MarketBeat

Sep 03, 2024
pulisher
Sep 02, 2024

Short Interest in Gyre Therapeutics, Inc. (NASDAQ:GYRE) Grows By 5.4% - MarketBeat

Sep 02, 2024
pulisher
Aug 28, 2024

Gyre Therapeutics (NASDAQ:GYRE) Trading 4.1% Higher - MarketBeat

Aug 28, 2024
pulisher
Aug 27, 2024

Gyre Therapeutics (NASDAQ:GYRE) Shares Down 6.6% - MarketBeat

Aug 27, 2024
pulisher
Aug 26, 2024

Gyre Therapeutics (NASDAQ:GYRE) Sees Unusually-High Trading Volume - MarketBeat

Aug 26, 2024
pulisher
Aug 25, 2024

Bicara Therapeutics (NASDAQ:BCAX) Stock Quotes, Forecast and News Summary - Benzinga

Aug 25, 2024
pulisher
Aug 19, 2024

Gyre Therapeutics, Inc. (NASDAQ:GYRE) Sees Significant Growth in Short Interest - MarketBeat

Aug 19, 2024
pulisher
Aug 19, 2024

Gyre Therapeutics (NASDAQ:GYRE) Stock Price Up 8.2% - MarketBeat

Aug 19, 2024
pulisher
Aug 19, 2024

Vanguard Group Inc. Reduces Holdings in Gyre Therapeutics, Inc. (NASDAQ:GYRE) - Defense World

Aug 19, 2024
pulisher
Aug 15, 2024

Gyre Therapeutics (NASDAQ:GYRE) Shares Gap Up to $10.40 - MarketBeat

Aug 15, 2024
pulisher
Aug 13, 2024

GYRE Stock Earnings: Gyre Therapeutics Reported Results for Q2 2024 - InvestorPlace

Aug 13, 2024
pulisher
Aug 13, 2024

Gyre Therapeutics (NASDAQ:GYRE) Trading Down 3.9% - MarketBeat

Aug 13, 2024
pulisher
Aug 13, 2024

Gyre Therapeutics Reports Second Quarter 2024 and Year-To-Date Financial Results and Provides Business Update - BioSpace

Aug 13, 2024
pulisher
Aug 12, 2024

Gyre Therapeutics (NASDAQ:GYRE) Trading 6.7% Higher - MarketBeat

Aug 12, 2024
pulisher
Aug 09, 2024

Gyre Therapeutics to Present at Sidoti Virtual Investor Conference - ForexTV.com

Aug 09, 2024
pulisher
Aug 08, 2024

Gyre Therapeutics Welcomes Dr. Epstein to Leadership Team - TipRanks

Aug 08, 2024
pulisher
Aug 08, 2024

Gyre Therapeutics Announces Appointment of David M. Epstein, Ph.D., to Board of Directors - StockTitan

Aug 08, 2024
pulisher
Aug 07, 2024

Gyre Therapeutics (NASDAQ:GYRE) versus Insmed (NASDAQ:INSM) Critical Comparison - Defense World

Aug 07, 2024
pulisher
Aug 06, 2024

Gyre Therapeutics (NASDAQ:GYRE) Stock Price Up 8.4% - MarketBeat

Aug 06, 2024
pulisher
Aug 05, 2024

Gyre Therapeutics (NASDAQ:GYRE) Stock Price Down 18.9% - MarketBeat

Aug 05, 2024
pulisher
Jul 30, 2024

Gyre Therapeutics (NASDAQ:GYRE) Stock Price Down 8.4% - MarketBeat

Jul 30, 2024
pulisher
Jul 29, 2024

Gyre Therapeutics (NASDAQ:GYRE) Trading Up 4.9% - MarketBeat

Jul 29, 2024
pulisher
Jul 26, 2024

Gyre Therapeutics, Inc. (NASDAQ:GYRE) Short Interest Up 67.9% in July - MarketBeat

Jul 26, 2024
pulisher
Jul 21, 2024

Gyre Therapeutics (NASDAQ:GYRE) Shares Down 4.3% - Defense World

Jul 21, 2024
pulisher
Jul 19, 2024

Gyre Therapeutics (NASDAQ:GYRE) Trading Down 4.3% - MarketBeat

Jul 19, 2024
pulisher
Jul 18, 2024

Gyre Therapeutics, Inc. (NASDAQ:GYRE) Short Interest Update - Defense World

Jul 18, 2024
pulisher
Jul 18, 2024

Supply@ME Capital (LON:SYME) Stock Price Up 16.7% - Defense World

Jul 18, 2024
pulisher
Jul 15, 2024

Unicycive Therapeutics, Inc. (NASDAQ:UNCY) Short Interest Update - Defense World

Jul 15, 2024
pulisher
Jul 15, 2024

Head to Head Comparison: Puma Biotechnology (NASDAQ:PBYI) versus Gyre Therapeutics (NASDAQ:GYRE) - Defense World

Jul 15, 2024
pulisher
Jul 15, 2024

Adaptimmune Therapeutics plc (NASDAQ:ADAP) Short Interest Up 15.1% in June - Defense World

Jul 15, 2024
pulisher
Jul 14, 2024

Gyre Therapeutics (NASDAQ:GYRE) Stock Price Up 5.5% - Defense World

Jul 14, 2024
pulisher
Jul 08, 2024

Gyre Therapeutics (NASDAQ:GYRE) Stock Price Down 4.3% - MarketBeat

Jul 08, 2024
pulisher
Jul 07, 2024

Gyre Therapeutics (NASDAQ:GYRE) Shares Up 3.7% - Defense World

Jul 07, 2024
pulisher
Jul 06, 2024

Gyre Therapeutics faces Nasdaq delisting over audit rule - Investing.com India

Jul 06, 2024
pulisher
Jul 05, 2024

Gyre Therapeutics faces Nasdaq delisting over audit rule By Investing.com - Investing.com

Jul 05, 2024
pulisher
Jul 05, 2024

Gyre Therapeutics Seeks Compliance Amid Board Reshuffle - TipRanks

Jul 05, 2024

Finanzdaten der Gyre Therapeutics Inc-Aktie (GYRE)

Es liegen keine Finanzdaten für Gyre Therapeutics Inc (GYRE) vor. Überprüfen Sie andere Aktien für weitere Informationen.

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Gyre Therapeutics Inc-Aktie (GYRE) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
USMAN NASSIM
Director
Jun 28 '24
Sale
12.00
3,452
41,438
1,636
USMAN NASSIM
Director
May 01 '24
Option Exercise
6.93
20,000
138,600
21,636
USMAN NASSIM
Director
May 01 '24
Sale
14.13
20,000
282,577
1,636
USMAN NASSIM
Director
Apr 01 '24
Option Exercise
6.93
20,000
138,600
21,636
USMAN NASSIM
Director
Apr 01 '24
Sale
16.15
20,000
323,000
1,636
USMAN NASSIM
Director
Mar 15 '24
Option Exercise
6.93
20,000
138,600
21,636
USMAN NASSIM
Director
Mar 15 '24
Sale
17.26
20,000
345,200
1,636
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
Kapitalisierung:     |  Volumen (24h):